H.C. Wainwright Forecasts 2026 Data Readouts for Climb Bio’s (CLYM) Budoprutug Across Clinical Tracks
Climb Bio Inc. (NASDAQ:CLYM) is one of the best biotech penny stocks to buy according to analysts. On December 18, H.C.
Climb Bio Inc. (CLYM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 11,293,828 | $77,711,233 | -65% | 0.8% |
| 2. | BioImpact Capital Mpm Capital | 2,671,480 | $10,685,920 | 1.22% | |
| 3. | ADAR1 Capital Management Daniel Schneeberger | 1,432,475 | $5,729,900 | +973% | 0.42% |
| 4. | Kynam Capital Derrick Tang | 1,028,341 | $4,113,364 | 0.26% | |
| 5. | Great Point Partners Jeffrey Jay And David Kroin | 979,534 | $3,918,136 | 1.27% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.50 | 7,111 | $24,888.50 | 3,403,429 | 2026-01-05 | Filing | |
| $2.86 | 101,462 | $290,181.32 | 3,396,318 | 2025-12-12 | Filing | |
| $2.18 | 213,099 | $464,555.82 | 3,294,856 | 2025-12-11 | Filing | |
| $3.84 | 1,059,375 | $4,068,000.00 | 2,866,375 | 2024-06-27 | Filing | |
| $3.84 | 11,949,171 | $45,884,816.64 | 23,521,757 | 2024-06-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.81 | 10,000 | $58,141.00 | 204,657 | 2026-02-13 | Filing | |
| $5.23 | 90,000 | $470,988.00 | 214,657 | 2026-02-12 | Filing | |
| $1.22 | 20,618 | $25,153.96 | 48,132 | 2025-06-30 | Filing | |
| $1.24 | 1,242 | $1,540.08 | 18,888 | 2025-06-20 | Filing | |
| $1.31 | 1,199 | $1,570.69 | 15,130 | 2025-03-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,340,504 | $5,362,016 | 0% | |
| 2. | 1,300,000 | $5,200,000 | 0.3% | |
| 3. | 566,712 | $2,266,848 | 0% | |
| 4. | 565,992 | $2,263,968 | 1.93% | |
| 5. | 463,654 | $1,854,616 | 0.15% |
News See All
10 Best Biotech Penny Stocks to Buy According to Analysts
On December 24, Jared Holz of Mizuho joined 'Power Lunch' on CNBC to talk about how to play biotech moving into 2026.
William Blair Initiates Coverage of Climb Bio (CLYM) with Outperform Rating on Autoimmune Drug Potential
Climb Bio Inc. (NASDAQ:CLYM) is one of the best stocks under $3 to invest in.
10 Best Stocks Under $3 to Invest In
On October 16, Victoria Greene, Chief Investment Officer of G Squared Private Wealth Management, appeared on CNBC to state that small caps demonstrate lasting strength.
Hedge Fund Resource Center Billionaire Hedge Funds
